About Us

The Staphylococcus aureus bacteraemia Network Adaptive Platform Trial is an innovative trial to evaluate a range of interventions with the aim of improving outcomes for patients with Staphylococcus aureus bacteraemia (AKA bloodstream infections). 

The study includes sites from throughout Australia, New Zealand, Singapore, Canada and Israel and has the potential to include sites elsewhere in the world.

Snap Team

Co-ordinating Investigators

Meet the SNAP Team
Zoe McQuilten

Independent Chair, Trial Steering Committee

Joshua Davis

Professor Joshua S Davis PhD, FRACP, MBBS (Hons), DTM&H, Grad Cert Pop Health. Infectious Diseases Physician and NHMRC Career Development Fellow at the University of Newcastle and the Menzies School of Health Research.